HHS Extends Broad Immunity for Liability Arising From COVID-19 Countermeasures
March 18, 2020
DOCUMENTS
- Notice
WASHINGTON, D.C. — The United States Department of Health and Human Services has conferred broad-based tort immunity for drug and medical device makers and others engaging in “activities related to medical countermeasures against COVID-19.”
According to a March 17 notice of declaration published in the Federal Register, the immunity extends to “any claim of loss caused by, arising out of, relating to, or resulting from the manufacture, distribution, administration, or use of medical countermeasures.”
The immunity extends to “any claim of loss caused by, arising out of, relating to, or resulting from the manufacture, distribution, administration, or use of …
UPCOMING CONFERENCES
HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates
May 29, 2024 - Salt Lake City, UT
The Grand America Hotel
HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone
June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo